OM-X ® is a hand-made and naturally manufactured probiotic supplement. This fermented food product is made from vegetables, fruits, seaweeds and mushrooms, using 12 strains of lactic acid bacteria and bifidobacteria. OM-X ® is also known to have beneficial health properties, and some of its components show effects on antigen (Ag)-stimulated degranulation activity, indicating that OM-X ® may be useful in the treatment of allergy responses and symptoms. In this study, we evaluated the inhibitory effects of OM-X ® on Ag-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells, clarified the underlying mechanisms, and determined the active compounds in OM-X ® for suppression of degranulation. Treatment with OM-X ® gradually suppressed Ag-stimulated degranulation throughout the maturation period. OM-X ® also gradually produced melanoidins by lactic acid bacterial fermentation during the maturation process. There was a high correlation between the suppression levels of Ag-stimulated degranulation and the browning of OM-X ® . Furthermore, the inhibition of Ag-stimulated degranulation by OM-X ® was found to be partially due to the direct inactivation of NADPH oxidase. To elucidate the in vivo effects of OM-X ® , type I allergy model mice were orally administered with OM-X ® , and the passive cutaneous anaphylaxis (PCA) reaction was measured. OM-X ® intake remarkably suppressed the PCA reaction. Taken together, our findings suggest that OM-X ® could be a beneficial food to ameliorate allergic reactions.
Type I allergy or immediate-type hypersensitivity is implicated in various allergic symptoms including rhinitis, conjunctivitis, bronchial asthma, and urticarial. Mast cells are the key effector cells that cause these allergic symptoms. High-affinity immunoglobulin E (IgE) receptor (FcεRI) is expressed on the surface of mast cells and basophils, and IgE binds to the FcεRIα chain. Cross-linking of IgE-mediated by the binding of multivalent antigen on the surfaces of mast cells induces the release of intragranular mediators such as histamine, arachidonic acid metabolites, proteases, serotonin, and heparin [1] [2] [3] [4] . These mediators then trigger immediate allergic responses.
OM-X ® is a probiotic supplement that was manufactured by Dr Iichiroh Ohhira using a unique fermentation method. It is strictly hand-made and is comprised of all natural components. OM-X ® is a naturally fermented mixture of vegetables, fruits, seaweeds, and mushrooms, using 12 strains of lactic acid bacteria (LAB) and bifidobacteria. After 5 years of fermentation at room temperature, the fermented mixture contains probiotics, prebiotics such as oligosaccharides and dietary fiber, and trace amounts of vitamins, minerals, short-chain fatty acids, and amino acids ( Figure 1) . In human clinical studies, OM-X ® has shown beneficial effects on bone health [5] , oral ulcerations [6] , and colitis [7] .
Recent studies demonstrated that carotenoids and flavonoids, which are present in the ingredients used in the manufacturing of OM-X ® , show effects on antigen (Ag)-stimulated degranulation [8, 9] . Natural materials that are fermented by LAB such as grape marc, have also been shown to suppress the type I allergic response, and thus, it seems, the allergy symptoms. Moreover, OM-X ® gradually produces melanoidins by LAB fermentation during the maturation process. However, scarce information is available on the relationship between melanoidins and allergy. The aim of this study was to evaluate the inhibitory effects of OM-X ® on Ag-stimulated degranulation in rat basophilic leukemia RBL-2H3 cells, clarify the underlying mechanisms, and determine the active compounds in OM-X ® for the suppression of degranulation. Furthermore, we evaluated the ability of oral administration of OM-X ® to inhibit type I allergy symptoms in model mice.
In the present study, we evaluated the anti-degranulation activity of OM-X ® and the underlying inhibitory mechanisms on Agchallenged degranulation. OM-X ® resulted in gradual inhibition of Ag-stimulated degranulation in RBL-2H3 cells, and the inhibitory effect increased in a time-and dose-dependent manner ( Figure 2 ). Interestingly, there was a high correlation between the inhibitory activities of OM-X ® on Ag-stimulated degranulation in RBL-2H3 cells and the browning of OM-X ® (R = 0.9802, Figure 2A and Figure 3 ). OM-X ® is made from natural ingredients (44%, w/w), sugar (55.4%, w/w), and 12 strains of LAB and bifidobacteria (0.6%). During the maturation, amino acids derived from the NPC Natural Product Communications 2015 Vol. 10 No. 9 1597 -1601 mixture of natural ingredients react with sugar owing to the heat produced during fermentation (Maillard reaction), generating the brown melanoidins. Thus, it was considered that the carotenoids [10] and flavonoids [11, 12] contained in the ingredients used for making OM-X ® had no effect on the Ag-stimulated degranulation, as these compounds would likely be broken down by fermentation. Since melanoidins are well known to function as antioxidant/radical-scavengers [13] [14] [15] , we measured the DPPH radical scavenging activity of OM-X ® . The antioxidant activities of 5-year-matured OM-X ® were dramatically increased 5.3-fold compared with those of 1-year-matured OM-X ® . There was also a high correlation between the browning of OM-X ® and its antioxidant activity (R = 0.9787), indicating that these scavenging activities were likely involved in the generation of melanoidins during the maturation process. The half-maximal concentration (ED 50 ) for the antioxidant activities of 5-year-matured OM-X ® was approximately 200 μg/mL ( Figure 4A ), which was 20-fold lower than that of L-ascorbic acid (positive control, Figure 4B ). Collectively, these results suggest that the melanoidins generated during fermentation contribute to inhibition of Ag-stimulated degranulation in RBL-2H3 cells. To gain further insight into the mechanisms underlying the inhibitory effects of OM-X ® on Ag-stimulated degranulation, we first measured the changes of intracellular ROS production and the levels of Ca 2+ mobilization in Ag-stimulated RBL-2H3 cells treated with or without OM-X ® . As shown in Figure 5 , 250 μg/mL of OM-X suppressed ROS production to the same extent as diphenyleneiodonium (DPI). OM-X ® also suppressed the levels of Ca 2+ mobilization to a similar level observed in untreated cells ( Figure 6 ). Furthermore, OM-X ® suppressed the translocation of Rac, a cytosolic subunit of NADPH oxidase, to the plasma membrane ( Figure 7 ). These results demonstrate that the general mechanism of degranulation inhibition involves direct inactivation of NADPH oxidase. Upon Ag-stimulated degranulation, the level of intracellular ROS is elevated by NADPH oxidase activation. NADPH oxidase is an enzyme complex composed of membranebound subunits (gp91 phox and p22 phox ), cytosolic subunits (p40 phox , p47 phox , and p67 phox ), and a monomeric GTP-binding protein of the Rho family Rac [16, 17] . To activate phagocytic NADPH oxidase, the cytosolic subunits are translocated to the membrane, thus initiating production of superoxide [18] . The superoxide produced following Ag stimulation is then readily converted to hydrogen peroxide, which in turn regulates the Ca 2+ channel on the cell surface, thus controlling Ca 2+ influx from the extracellular medium [19] . After Ag stimulation, signal transduction for degranulation and cytokine production in mast cells is immediately activated following aggregation of FcεRI [20] . Translocation of cytosolic subunits of NADPH oxidase to membrane-bound subunits proceeds through the phosphorylation of Syk. Thus, we further examined the early intracellular signaling transduction pathways involved in OM-X ® on suppressing the responses to Ag stimulation. The data presented in Figure 8 show that OM-X ® treatment had no effect on the Lyn/Syk/PLCγ pathway, PI3K/Akt, and MAP kinases in Agchallenged RBL-2H3 cells. Thus, the production of intracellular ROS was due to the direct suppression of the translocation of cytosolic subunits of NADPH oxidase and the scavenging of ROS by OM-X ® 's own antioxidative activity ( Figure 9 ). To examine the effect of OM-X ® on the type I allergy response, we evaluated the PCA reaction in type I allergy model mice. Oral administrations of OM-X ® (low-dose group: 2.5 g·60 kg body weight -1 ·day -1 , high-dose group; 5.0 g·60 kg body weight -1 ·day -1 ) decreased the amount of extravasated dye in a dose-dependent manner ( Figure 10 ). In particular, the PCA reaction was suppressed to the same extent in the high-dose group as in the negative control group, which was treated with anti-DNP-IgE without Ag stimulation. Therefore, OM-X ® intake likely contributes to suppression of allergic symptoms, and would be a beneficial natural material for the treatment of type I allergy.
Taken together, our findings suggest that the inhibitory effect of OM-X ® on Ag-stimulated degranulation was due, at least in part, to the suppression of intracellular Ca 2+ mobilization through inhibition of the translocation of cytosolic subunits of NADPH oxidase to membrane-bound subunits and direct scavenging of ROS that are produced by NADPH oxidase. 
Experimental

Reagents and materials:
Mouse anti-dinitrophenol (DNP) monoclonal IgE was purchased from Yamasa (Tokyo, Japan). The 25 × Complete ® , a mixture of proteinase inhibitors and the phosphatase inhibitor PhoSTOP ® were from Roche (Penzberg, Germany). The antibodies to Akt, phospho-Akt, p44/42 MAPkinase (ERK), phospho-p44/42 MAPkinase (Thr202/tyr204) (p-ERK), SAPK/JNK (JNK), phospho-SAPK/JNK (Thr183/Tyr185) (p-JNK), p38 MAP kinase (p38), phospho-p38 MAP kinase (Thr180/Tyr182) (p-p38), Lyn, phospho-Lyn, phospho-PLCγ1, phospho-PLCγ2, Syk, and Rac were from Cell Signaling Technology (MA, USA). The antibody to gp91 phox was from Santa Cruz Biotechnology (CA, USA). The antibody to was phospho-Syk (p-Syk) from Abcam (MA, USA).
Cell culture: RBL-2H3 cells were obtained from the Health Science Research Resource Bank (Tokyo, Japan). Cells were grown in Eagle's minimum essential medium (Life Technologies; Carlsbad, CA, USA) containing 10% heat-inactivated fetal bovine serum, 100 U/mL of penicillin, and 100 mg/mL of streptomycin in a humidified atmosphere of 5% CO 2 at 37°C.
OM-X ® preparation:
The OM-X ® sample was provided by BIOBANK Co., Ltd. (Okayama, Japan). All plant ingredients used in OM-X ® are nutritionally rich and safe for human consumption. The general procedure involves loading each ingredient into the manufacturing vats one by one at the different stages of fermentation. When each ingredient is added, it is fermented by LAB to produce various organic acids and amino acids. In addition, the solid ingredients are broken down to facilitate absorption of their components through fermentation. Thus, various ingredients that are beneficial to human health are fermented and matured for 5 years. In the OM-X ® used in the current study, 12 strains of LAB were added to ferment and mature the plant ingredients. One of the strains has very high proteolytic capability, which was isolated and identified from tempeh. The specific ingredients used for OM-X ® production and the composition of organic acids and carbohydrates in OM-X ® are shown in Tables 1 and 2 . OM-X ® was determined to be safe for human consumption with no adverse health effects, according to a single-dose oral toxicity test conducted by Mitsubishi Chemical Safety Institute Ltd. (Tokyo, Japan). 
Degranulation assay β-Hexosaminidase release assay:
We used β-hexosaminidase as a marker of degranulation. RBL-2H3 cells (2 ×10 4 cells/well) were seeded onto 24-well plates and cultured for 12 h. Cells were then treated with anti-DNP-IgE (0.45 μg/mL) and incubated for 24 h. After washing twice with Siraganian buffer A (119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM PIPES, and 40 mM NaOH, pH 7.2), 160 μL of Siraganian buffer B {5.6 mM glucose, 1 mM CaCl 2 , and 0.1% bovine serum albumin (BSA)} was added to each well. After incubating at 37°C for 10 min, cells were treated with the OM-X ® at 37°C for a further 30 min. DNP-labeled BSA (DNP-BSA; 20 μL) was then added to the culture medium to a final concentration of 10 μg/mL. After 10 min, cells were placed on ice for 10 min to terminate the reaction. The supernatants were then harvested by centrifugation at 300 × g at 4°C for 10 min. The supernatants (50 mL) were transferred into 96-well microplates and allowed to react with 50 μL of 0.1 M citrate buffer (pH 4.5) that contained 1 mM p-nitrophenyl-N-acetyl-β-D-glucosaminide (CB-PNAG) at 37°C. The reaction was terminated after 1 h by adding stop buffer (0.1 M Na 2 CO 3 /NaHCO 3 , pH 10.0). Absorbance was measured at 405 nm using a colorimetric microplate reader (Corona Grating Microplate Reader SH-9000, Corona Electric Co. Ltd.; Hitachinaka, Ibaraki, Japan). β-Hexosaminidase inhibitory activity: Samples (5 μL) and conditioned medium prepared from Ag-stimulated RBL-2H3 cells (45 μL) were placed in the wells of 96-well microplates, and reacted with 50 μL of 0.1 M CB-PNAG at 37°C for 1 h. After terminating the reaction, the absorbance at 405 nm was measured. The inhibition of degranulation was calculated as follows: 
Measurement of intracellular Ca 2+ concentrations: Intracellular
Ca 2+ levels were determined with a Calcium Kit-Fluo 3™ (Dojindo Laboratories; Kumamoto, Japan). RBL-2H3 cells (5 × 10 4 cells/well) were seeded onto 96-well microplates and incubated for 1 h. The cells were then treated with anti-DNP IgE (0.45 μg/mL) and incubated for 24 h. After washing twice with phosphatebuffered saline (PBS), 100 μL of loading buffer containing Fluo-3AM (Calcium Kit-Fluo 3™) was added to the culture medium. One hour later, the cells were washed with PBS and incubated in 90 μL of loading buffer containing OM-X ® . After incubation for 30 min, cells were stimulated by DNP-BSA (10 μg/mL) and the fluorescence was measured using a fluorometric imaging plate reader (excitation: 490 nm, emission: 530 nm).
Measurement of intracellular reactive oxygen species (ROS) levels:
Intracellular ROS levels were measured by using the general marker of oxidative stress CM-H 2 DCF-DA. IgE-sensitized RBL-2H3 cells (5 × 10 4 cells/well) were incubated with 10 μM CM-H 2 DCF-DA for 30 min at 37°C. After washing twice with Siraganian buffer A, cells were incubated with Siraganian buffer B including OM-X ® for 30 min. Then, the cells were stimulated with DNP-BSA (10 μg/mL), and the fluorescence was measured using the fluorometric imaging plate reader (excitation: 490 nm, emission: 530 nm).
Measurement of DPPH radical-scavenging activity:
To measure in vitro anti-oxidant activity, the DPPH radical-scavenging assay was carried out as described previously. Briefly, 180 μL of 0.2 mM DPPH radical solution and 20 μL of OM-X ® were rapidly mixed and the decrease in absorbance at 517 nm was monitored. DPPH free radical-scavenging activity (%) was calculated using the following formula:
[(A 517nm of control − A 517nm of sample ) /A 517nm of control ] × 100 Vitamin C (L-ascorbic acid, Wako Pure Chemical Co. Ltd.; Osaka, Japan), a potent anti-oxidant, was used as a positive control.
Immunoblot analysis:
Cell lysates were prepared as described previously. The cytosolic and membrane fractions were separated OM-X ® , a beneficial food to ameliorate allergic reactions Natural Product Communications Vol. 10 (9) 2015 1601 using the ProteoExtract subcellular proteome extraction kit (Merck KGaA; Darmstadt, Germany). Protein samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then transferred onto polyvinylidene fluoride membranes. After blocking for 1 h in 5% non-fat milk, the membrane was incubated with a primary antibody at 4°C overnight, followed by incubation with a horseradish peroxidase-conjugated secondary antibody at room temperature for 1 h. Immunoreactive proteins were detected with an enhanced ECL kit and a Davinch-Chemilumino-image analyzer (Wako).
Animals and diets:
Four-week-old ICR male mice (Japan SLC, Ltd.; Hamamatsu, Japan) were housed in an air-conditioned room (22±2°C) with a 12-h light and dark cycle (lighting from 0700 to 1900). All mice were fed commercial CE-2 pellets (Clea Japan Inc.; Tokyo, Japan) and water ad libitum for 1 week to acclimatize them to their surroundings. After 1 week, each mouse was treated with 100 μL of either PBS or OM-X ® (2.5 or 5.0 g/60 Kg body weight/day) by oral administration for 4 weeks. This study was approved by the Kinki University Animal Use Committee, and animals were maintained according to the guidelines of the Kinki University for the care of laboratory animals.
Measurement of the mouse passive cutaneous anaphylaxis (PCA) reaction:
The IgE-induced PCA reaction was measured according to a previously published method [21] , with the following slight modification. The back hair of the ICR mice was shaved, and 10 mg of anti-DNP-IgE was injected into 2 dorsal skin sites per mouse. The sites were outlined with a water-insoluble marker. Twenty four hours later, each mouse received an injection of 200 μL of DNP-BSA of 1% Evans blue (Sigma) in PBS, containing 200 μg of DNP-BSA. Treated mice were sacrificed 1 h later, and their dorsal skin was removed. Skin pieces (1 cm) were dissolved with 1 N KOH at 37°C for 24 h, and the extravasated Evans blue dye was extracted with a mixture of acetone and 0.2 M phosphoric acid (13:5) from the treated skin solution. The amount of dye was determined colorimetrically at 620 nm.
Statistical analysis:
All data were analyzed using the Mac statistical analysis software package for Macintosh, version 2.0 (Esumi Co.; Tokyo Japan). All data are expressed as means ± standard error (S.E.). Statistical analysis was performed using the Tukey-Kramer test for comparisons among many groups or the Student's t-test for comparisons between 2 groups, at a significance level of p < 0.01.
